• Customer portal
logo logo
  • Start
  • Products
    • Our products
    • Ultrasound
    • Radiography
    • MRI
    • Mammography
  • Pathology
    • Digital Pathology
    • INIFY™ Prostate
    • MasterAnnotation™
    • Advisory Board
    • Challenges
    • News
    • Publications
    • Sign Up
  • Technology
    • Our technology
    • Research & Development
    • The GOP technology
    • Artificial intelligence
  • News
    • News
    • Events
    • In the media
  • Investors
    • Investor news
    • Webcast
    • Financial reports
    • Corporate governance
    • Company overview
    • The share
    • Subscription
  • Company
    • About ContextVision
    • Management
    • Board of directors
    • Career
    • ContextVision quality policy
  • Career
  • Contact
    • Sales Digital Pathology
    • Sales OEM Medical Imaging
    • OEM Medical Imaging
    • Digital Pathology
    • Customer Support
    • Investor relations & Media
    • Headquarters
    • Human Resources
  • HEJ!
    • Research & Development
    • Artificial intelligence
    • The GOP technology
logo logo
  • Start
  • State-of-the-art products
    • Our products
    • Ultrasound
    • Radiography
    • Magnetic Resonance Imaging
    • Mammography
  • Technology
    • Our technology
    • Research & Development
    • The GOP technology
    • Artificial intelligence
  • Pathology
    • Digital Pathology
    • INIFY™ Prostate
    • MasterAnnotation™
    • Advisory Board
    • Challenges
    • News
    • Publications
    • Sign up
  • News
    • Latest news
    • Latest events
    • In the media
  • Investors
    • Investor news
    • Webcast
    • Financial reports
    • Corporate governance
    • Company overview
    • The share
    • Subscription
  • Company
    • About
    • Management
    • Board of Directors
    • Career
    • ContextVision quality policy
  • Contact
  • Customer Portal
Webcast2012-07-02

Q1 2012, report

Highlights:
• Sales increase 15 %
• Large customers broadening future commitment.
• Increase of market share in XR
• Government Contribution of 1.4 MSEK for mammography product development

Click to view Webcast Q1 2012

Previous ContextVision in scientific collaboration with Karolinska Institute
Next Summer Greetings
© ContextVision AB (publ)